Study of Low-Grade Endometrial Stromal Sarcoma
Author Information
Author(s): Ashraf-Ganjoei Tahereh, Behtash Nadereh, Shariat Mamak, Mosavi Asamosadat
Primary Institution: Gynecologic Oncology Department, Vali Asr Hospital, Tehran, Iran
Hypothesis
What are the clinical and pathological features of low-grade endometrial stromal sarcoma and their prognostic factors?
Conclusion
The five-year survival rate for patients with low-grade endometrial stromal sarcoma was found to be 93%.
Supporting Evidence
- The most common symptom was vaginal bleeding, reported by 86% of patients.
- The median follow-up time was 45.6 months.
- No patient died of the disease during the study period.
- Patients with no myometrial invasion and low mitotic count showed longer disease-free survival.
Takeaway
This study looked at 14 women with a rare type of cancer called low-grade endometrial stromal sarcoma and found that most of them lived for at least five years after treatment.
Methodology
The study included 14 patients with histologically proven low-grade endometrial stromal sarcoma, analyzing their clinical and pathological features and treatment outcomes.
Limitations
The small sample size limits the generalizability of the findings.
Participant Demographics
The median age of participants was 44.35 years, with a range of 33 to 52 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website